Abstract
The importance, implications, and potential value of pharmacologic interventions during healing of the wound of myocardial infarction have become apparent as a result of recent advances in pathophysiology of healing and ventricular remodeling post-infarction. Over the last three decades, therapeutic efforts after myocardial infarction have centered around minimizing the loss of myocardium and function. Therapy focused on acute reduction of myocardial infarct size in the mid-seventies and on restoration of perfusion in the infarct zone in the mid-eighties. Over the last decade, chronic therapies have been developed for prevention of ventricular remodeling, progressive ventricular dilation and ventricular dysfunction [1, 2]. It became evident during the last 30 years that some pharmacologic therapies aimed at salvaging ischemic myocardium also exerted other effects on infarct healing, and those with clearly adverse effects were best avoided [3–7]. Recognition that the substrate for ventricular remodeling changes during infarct healing led to the suggestion that timing and duration of specific antiremodeling interventions should be based on knowledge of the natural pathophysiologic stage of healing in order to maximize therapeutic benefits [2, 8, 9]. To date, therapies have not been primarily targeted at improving the healing process post-infarction. This chapter will review current and potential pharmacologic interventions in post-infarction wound healing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161 –72.
Jugdutt BI. Prevention of ventricular remodelling post myocardial infarction: timing and duration of therapy. Can J Cardiol 1993; 9: 103 – 14.
Brown EJ, Kloner RA, Schoen FJ, Hammerman H, Hale S, Braunwald E. Scar thinning due to ibuprofen administration following experimental myocardial infarction. Am J Cardiol 1983; 51: 877 – 83.
Hammerman H, Schoen FJ, Braunwald E, Kloner RA. Drug-induced expansion of infarct: Morphologic and functional correlations. Circulation 1984; 69: 611 – 17.
Jugdutt BI. Delayed effects of early infarct-limiting therapies on healing after myocardial infarction. Circulation 1985; 72: 907 – 14.
Jugdutt BI, Basualdo CA. Myocardial infarct expansion during indomethacin or ibuprofen therapy for symptomatic post-infarction pericarditis. Influence of other pharmacologic agents during early remodeling. Can J Cardiol 1989; 5: 211 – 21.
Jugdutt BI. Effect of nitroglycerin and ibuprofen on left ventricular topography and rupture threshold during healing after myocardial infarction in the dog. Can J Physiol Pharmacol 1988; 66: 385 – 95.
Michorowski BL, Tymchak WJ, Jugdutt BI. Improved left ventricular function and topography by prolonged nitroglycerin therapy after acute myocardial infarction (Abstract). Circulation 1987; 76 (Suppl IV): IV–128.
Jugdutt BI, Tymchak WJ, Humen DP, Gulamhusein S, Tang SB. Effect of thrombolysis and prolonged Captopril and nitroglycerin on infarct size and remodeling in transmural myocardial infarction (Abstract). J Am Coll Cardiol 1992; 19: 205A.
Mallory GK, White PD, Salcedo-Salgar J. The speed of healing of myocardial infarction: A study of the pathological anatomy in 72 cases. Am Heart J 1939; 18: 647 – 71.
Fishbein MC, Maclean D, Maroko PR. The histopathologic evolution of myocardial infarction. Chest 1978; 73: 843 – 9.
Roberts CS, Maclean D, Maroko P, Kloner RA. Early and late remodeling of the left ventricle after acute myocardial infarction. Am J Cardiol 1984; 54: 407 – 10.
Jugdutt BI, Any RWM. Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography. J Am Coll Cardiol 1986; 7: 91 – 102.
Wahl ML, Wahl SM. Inflammation. In: Cohen KI, Diegelmann RF, Lindblad WJ, editors: Wound healing: Biochemical and clinical aspects. Philadelphia: Saunders, 1992: 40 – 62.
Streeter DD. Gross morphology and fiber geometry of the heart. In: Berne RM, editor: The cardiovascular system. Volume 1. Bethesda: William and Williams, 1979: 61 – 112.
Hutchins GM, Bulkley BH. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol 1978; 41: 1127 – 32.
Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction. N Engl J Med 1979; 300: 57 – 62.
Caulfield JB, Borg TK. The collagen network of the heart. Lab Invest 1979; 40: 364 – 72.
Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 1989; 13: 1637 – 52.
Fujiwara H, Ashraf M, Sato S, Millard R. Transmural cellular damage and blood flow distribution in early ischemia in pig heart. Circ Res 1982; 51: 683 – 93.
Zhao M, Zhang H, Robinson TF, Factor SM, Sonnenblick EH, Eng C. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional (“stunned”) but viable myocardium. J Am Coll Cardiol 1987; 10: 1322 – 34.
Robinson TF, Geraci MA, Sonnenblick EH et al. Coiled perimysial fibers of papillary muscle in rat heart: Morphology, distribution, and changes in configuration. Circ Res 1988; 63: 577 – 92.
Covell JW. Factors influencing diastolic function. Possible role of the extracellular matrix. Circulation 1990; 81 (Suppl III): III-115–58.
Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation 1988; 78: 186 – 201.
Whittaker P, Boughner DR, Kloner RA. Analysis of healing after myocardial infarction using polarized light microscopy. Am J Pathol 1989; 34: 879 – 93.
Olivetti G, Capasso JM, Sonnenblick EH, Anversa P. Side-to-side slippage of myocytes participates in ventricular remodeling acutely after myocardial infarction in rats. Circ Res 1990; 67: 23 – 34.
Takahashi S, Barry AC, Factor SM. Collagen degradation in ischemic rat hearts. Biochem J 1990; 265: 233 – 41.
Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res 1974; 34/35 (Suppl 2): 17.
Olivetti G, Anversa P, Loud AV. Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. 2. Tissue composition, capillary growth, and sarcoplasmic alterations. Circ Res 1980; 46: 503 – 12.
Thompson NL, Bazoberry F, Speir EH, Casscells W, Ferrans VJ, Flanders KC, Kondaiah P, Geiser AG, Sporn MB. Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors 1988; 1: 91 – 9.
Michel JB, Lattion AL, Salzmann JL, Cerol ML, Philippe M, Camilleri JP, Corvol P. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988; 62: 641 – 50.
Litwin SE, Litwin CM, Raya TE, Warner AL, Goldman S. Contractility and stiffness of non-infarcted myocardium after coronary ligation in rats. Effects of chronic angiotensin converting enzyme inhibition. Circulation 1991; 83: 1028 – 37.
Gaudron P, Eilles C, Kugler I, Erti G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993; 87: 755 – 63.
Bulkley BH, Roberts WC. Steroid therapy during acute myocardial infarction: A cause of delayed healing and of ventricular aneurysm. Am J Med 1974; 56: 244 – 50.
Hammerman H, Kloner RA, Hale S, Schoen FJ, Braunwald E. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation 1983; 68: 446 – 52.
Hammerman H, Kloner RA, Schoen FJ, Brown EJ, Hale S, Braunwald E. Indomethacin-induced scar thinning following experimental infarction. Circulation 1983; 67: 1290 – 5.
Jugdutt BI, Hutchins GM, Bulkley BH, Pitt B, Becker LC. Effect of indomethacin on collateral blood flow and infarct size in the conscious dog. Circulation 1979; 59: 734 – 43.
Jugdutt BI, Hutchins GM, Bulkley BH, Becker LC. Salvage of ischemic myocardium by ibuprofen during infarction in the conscious dog. Am J Cardiol 1980; 46: 74 – 82.
Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Jransmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979; 40: 633 – 44.
Hochman JS, Choo H. Limitation of myocardial expansion by reperfusion independent of myocardial salvage. Circulation 1987; 75: 299 – 306.
Boyle MP, Weisman HF. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model. Circulation 1993; 88: 2872 – 83.
Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/ reperfusion: resolved and unresolved issues. Circulation 1989; 80: 1115 – 27.
Ambrosio G, Becker LC, Hutchins GM, Weisman HF, Weisfeldt ML. Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into pathophysiology of reperfusion injury. Circulation 1986; 74: 1424 – 33.
Przyklenk K, Kloner RA. Effect of verapamil on postischemic “stunned” myocardium: importance of timing of treatment. J Am Coll Cardiol 1988; 11: 614 – 23.
Jugdutt BI, Khan MI. Effect of prolonged nitrate therapy on left ventricular remodeling after canine acute myocardial infarction. Circulation 1994; 89: 2297 – 307.
Jugdutt BI, Khan MI, Jugdutt SJ, Blinston GE. Combined Captopril and isosorbide dinitrate during healing after myocardial infarction. Effects on ventricular remodeling, function, mass and collagen. J Am Coll Cardiol 1995; 25: 1089 – 96.
Jugdutt BI, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complications. Effect of timing, dosage and infarct location. Circulation 1988; 78: 906 – 19.
Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic Captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985; 57: 84 – 95.
Jugdutt BI, Schwarz-Michorowski BL, Khan MI. Effect of long-term Captopril therapy on
left ventricular remodeling and function during healing and canine myocardial infarction. J Am Coll Cardiol 1992; 19: 713 – 21.
Jugdutt Bí, Humen DP, Khan MI, Schwarz-Michorowski BL. Effect of left ventricular unloading with Captopril on remodelling and function during healing of anterior transmural myocardial infarction in the dog. Can J Cardiol 1992; 8: 151 – 63.
van Krimpen C, Schoemaker RG, Cleutjens JPM, Smits JFM, Struyker-Boudier HAJ, Bosman FT, Daemen MJAP. Angiotensin I converting enzyme inhibitors and cardiac remodeling. Basic Res Cardiol 1991; 86: 149 – 55.
Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown Jr EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM on behalf of the SAVE investigators. Effect of Captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327: 669 – 77.
Jugdutt BI, Khan MI, Jugdutt SJ, Blinston GE. Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Circulation 1995; 91: 802 – 12.
Litwin SE, Litwin CM, Raya TE, Warner AL, Goldman S. Contractility and stiffness of non-infarcted myocardium after coronary ligation in rats. Effects of chronic angiotensin converting enzyme inhibition. Circulation 1991; 83: 1028 – 37.
Yusuf S. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293 – 302.
Yusuf S. The SOLVD investigators. Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685 – 91.
Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H, for the CONSENSUS II study group. Effects of early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Co-operative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327: 678 – 84.
Ball SG. The acute infarction ramipril efficacy (AIRE) study investigators. Effect of ramipril on mortality and morbidity of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821 – 8.
Gruppo Italiano per lo Studio della Sopravvivenza nell’ Infarcto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115 – 22.
ISIS-4 (Fourth International Study of Infarct Survival) collaborative group. ISIS-4: A randomized factorial trial assessing early oral Captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected myocardial infarction. Lancet 1995; 345: 669 – 85.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Jugdutt, B.I. (1996). Pharmacological intervention in post-infarction wound healing. In: Karmazyn, M. (eds) Myocardial Ischemia: Mechanisms, Reperfusion, Protection. EXS, vol 76. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-8988-9_31
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8988-9_31
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-9857-7
Online ISBN: 978-3-0348-8988-9
eBook Packages: Springer Book Archive